Forte Biosciences, Inc. — Form D
Forte Biosciences, Inc. of Torrance, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-11. The offering totals $10.7M, of which $5.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-11
- Form: D
- Accession: 0001761323-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.7M
- Amount sold: $5.8M
- Remaining: $4.9M
- Investors: 12
- Date of first sale: 2018-11-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-327581
Issuer
- Name: Forte Biosciences, Inc.
- CIK: 0001761323
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1124 W. Carson Street, Torrance, CA, 90502
- Phone: 310-618-6994
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Lawrence Eichenfield | Director | Dallas, TX |
| Tuan Huynh | Director | Laguna Hills, CA |
| Paul Wagner | Director | Spokane, WA |
| Paul Wagner | Executive Officer | Spokane, WA |
| Antony A Riley | Executive Officer | Torrance, CA |
| Paul A Wagner, Ph.D. | Director | Torrance, CA |
| Paul A Wagner, Ph.D. | Executive Officer | Torrance, CA |
Other filings by this issuer (1)
More